1-Benzylpiperidine-3-carboxylic acid, 95.0%, 250mg

2-(2,3-Dihydrobenzo[b][1,4]dioxin-6-yl)acetic acid, 95.0%, 2.5g

1-(4-Bromo-phenyl)-5-methyl-1H-pyrazole-4-carboxylic acid, = 98.5% (HPLC), 1g

tert-Butyl 2,4-dioxo-2,3,4,5,6,8-hexahydropyrido[3,4-d]pyrimidine-7(1H)-carboxylate, 97%, 250mg

4-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)cyclohex-3-en-1-yl)morpholine, 95.0%, 50mg

5-Bromo-4-fluoro-2-nitrophenol, 97%, 250mg

3-Benzyloxybenzhydrazide, 97%+, 1g

1-{3-[methyl(phenyl)amino]propyl}-2,5-dihydro-1h-pyrrole-2,5-dione, 95%, 100mg

3-Bromo-5-fluoroisonicotinamide, 95.0%, 100mg

Sodium hydroxide solution, ROTI®Volum 0.5 mol/l - 0.5 N, ampoule, 1 piece, plastic packaging.

Methyl 2-formylpyridine-3-carboxylate, 97%, 250mg

1-(4,6-Dimethyl-pyrimidin-2-yl)-pyrrolidin-3-ol, 500mg

6-Bromo-1-indanone, 97.0%, 500g